Inventor · disambiguated record
Ikuo Tomino
Also filed as: TOMINO IKUO
10 granted patents·376 citations·filing 1987–1996
91Inventor score
Top patents by PatentIndex Score
10 records- 0196US5147876A2,6-di,2,4,6-, 2,5,6-tri and 2,4,5,6-tetra-substituted pyrimidines, their pharmaceutically acceptable salts, pharmaceutical compositions containing same and their use in the treatment of neurological diseasesMITSUI PETROCHEMICAL IND·Filed 1989·Granted Sep 15, 1992·177 cites·9 claims
- 0293US4959368ATherapeutic agent for neurological diseasesMITSUI PETROCHEMICAL IND·Filed 1987·Granted Sep 25, 1990·69 cites·43 claims
- 0382US5304555APyrimidines and pharmaceutically acceptable salts thereof useful in treatment of neurological disordersMITSUI PETROCHEMICAL IND·Filed 1990·Granted Apr 19, 1994·27 cites·24 claims
- 0480US5192799ACoumaran group containing amine compounds and their acid addition salts and quaternary ammonium salts and the use thereof as anti arrhythmic agents and as psychotropic agentsMITSUI PETROCHEMICAL IND·Filed 1992·Granted Mar 9, 1993·21 cites·16 claims
- 0571US5976523AMethod for healing compromised tissues using pyrimidine derivativesMITSUI PHARMACEUTICALS·Filed 1996·Granted Nov 2, 1999·46 cites·15 claims
- 0669US5358945APyrimidine compound and pharmaceutically acceptable salts thereofMITSUI PETROCHEMICAL IND·Filed 1991·Granted Oct 25, 1994·13 cites·4 claims
- 0763US4973588AImidazole derivatives having anti-hypoxia propertiesMITSUI PETROCHEMICAL IND·Filed 1989·Granted Nov 27, 1990·12 cites·22 claims
- 0854US4962200ANitrogen-containing compoundMITSUI PETROCHEMICAL IND·Filed 1988·Granted Oct 9, 1990·7 cites·19 claims
- 0951US5264435APyrimidines and their pharmaceutical acceptable salts, and their use as medicinesMITSUI PETROCHEMICAL IND·Filed 1992·Granted Nov 23, 1993·4 cites·5 claims
- 1027US4808726AProcess for preparation of guanidine derivativeMITSUI PETROCHEMICAL IND·Filed 1987·Granted Feb 28, 1989·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Ikuo Tomino files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →